靶材基本盘稳健，半导体零部件加速放量 [Table_Summary] 事件：据交易所互动平台，公司的超高纯金属溅射靶材和半导体精密半 导体零部件产品已批量供货给拥有三维集成和键合技术的半导体设备制 造企业、芯片制造企业。 点评 净利率提升显著， 毛利率有望得到修复 2025H1，公司实现净利率 11.12%（同比+3.29pct），毛利率 29.72%（同 比-1.28pct）。净利率提升显著主要系公司原材料采购的国产化、产业链 的本土化实现降本增效叠加投资净收益增厚利润；毛利率短期承压主要 系公司多个半导体精密零部件生产基地陆续完成建设并投产，处在产能 爬坡阶段尚未实现规模效益。未来，随着半导体零部件产能利用率提升 ，巩固全球溅射靶材行业头部企业地位，毛利率有望得到修复。 超高纯靶材基本盘稳健，半导体零部件有望打造第二增长曲线 [Table_Info1] 江丰电子(300666) 电子 [Table_Title] 证券研究报告 / 公司点评报告 超高纯金属溅射靶材：2025H1 公司实现营收 13.25 亿元（同比+23.91%）， 毛利率 33.26%（同比+2.93%）。受益于下游需求的旺盛增长与持续的 ...

Group 1 - Hefei Jinghe Integrated Circuit Co., Ltd. has officially submitted its listing application to the Hong Kong Stock Exchange, aiming for a main board listing [1] - The exclusive sponsor for this issuance is China International Capital Corporation (CICC) [1] - Jinghe Integrated Circuit specializes in semiconductor manufacturing, with products including logic chips, memory chips, and specialty process chips, widely used in smart terminals, automotive electronics, and the Internet of Things [3] Group 2 - The company has a strong market competitiveness in the domestic wafer foundry sector, achieving breakthroughs in advanced processes and specialty processes through continuous R&D and capacity expansion [3] - Jinghe Integrated Circuit's core production base is located in Hefei, with a production capacity for 12-inch wafers [3] - The company has been increasing its R&D investment and accelerating the layout of advanced process nodes, particularly in power management chips and display driver chips, establishing a stable customer base and promoting domestic substitution [3] Group 3 - The listing in Hong Kong is expected to help the company broaden its financing channels, enhance capital strength, and accelerate its international strategy, improving its competitive position in the global semiconductor supply chain [3] - The domestic wafer foundry industry is experiencing rapid development opportunities due to the continuous growth in global semiconductor market demand [3] - The company plans to use the funds raised from the listing to further expand production line construction, optimize product structure, and accelerate R&D investment in high-end processes, thereby continuously enhancing its core competitiveness and supporting the self-controllable development of China's semiconductor industry chain [3]

作为芯片制造的"地基"，12英寸硅片目前占据全球硅片出货面积的75%以上，且随着人工智能应用普及需求持续攀升。西安奕材专注于12英寸硅单晶抛光 片和外延片的研发、生产与销售，产品广泛应用于存储芯片、逻辑芯片、功率器件等领域，已供应智能手机、数据中心、新能源汽车等多个核心场景。截 至2024年末，公司月均出货量达52.12万片，产能稳居中国大陆第一、全球第六，在全球市场占比约6%-7%。 9月24日晚，西安奕斯伟材料科技股份有限公司（股票简称"西安奕材"，股票代码"688783.SH"）正式披露招股意向书，启动科创板IPO发行程序，标志着 这家国内12英寸硅片领军企业向资本市场迈出关键一步。 此次发行方案显示，西安奕材拟公开发行股票5.378亿股，占发行后总股本的13.32%，计划募资49亿元，全部投向西安奕斯伟硅产业基地二期项目。该项 目聚焦先进世代存储芯片用抛光片、更先进制程用外延片及功率器件用特色硅片的研发与生产，第二工厂已于2024年投产，预计2026年达产后，公司两厂 合计月产能将提升至120万片，可满足全球10%以上及中国大陆40%的12英寸硅片需求，有望跻身全球头部阵营。 技术实力与客户储备成为公 ...

截至2025年9月22日 09:57，上证科创板100指数上涨0.64%，成分股凌云光上涨8.32%，乐鑫科技上涨 6.33%，盛科通信上涨4.70%，国盾量子上涨4.65%，云天励飞上涨3.86%。科创100指数ETF(588030)盘 中最高上涨1.04%，现上涨0.59%，最新价报1.35元。拉长时间看，截至2025年9月19日，科创100指数 ETF近1周累计上涨1.66%。 流动性方面，科创100指数ETF盘中换手1.15%，成交7124.92万元。拉长时间看，截至9月19日，科创 100指数ETF近1年日均成交4.40亿元，排名可比基金第一。 【事件/资讯】 电子板块： 1、据报道，国家互联网信息办公室已要求国内大型科技企业暂停采购英伟达为中国市场定制的RTX Pro 6000D芯片，并取消现有订单。 2、据报道，OpenAI已与国内供应商达成协议，共同生产未来的OpenAI设备。OpenAI计划在2026年末 或2027年初推出其首款设备（智能眼镜、录音设备和别针式可穿戴装置）。 3、国产GPU厂商摩尔线程定于9月26日科创板IPO上会。 医药板块： 国家组织药品联合采购办公室9月20日发布《全 ...

Core Viewpoint - Hengkun New Materials Technology Co., Ltd. has received approval for its IPO on the Sci-Tech Innovation Board, marking a significant step for the company in the semiconductor materials sector and reflecting a key breakthrough in China's semiconductor industry chain autonomy [1][8]. Group 1: Company Overview - Hengkun New Materials focuses on the research, production, and sales of core materials for integrated circuit manufacturing, specifically photoresists and precursor materials [2]. - The company's product range includes SOC, BARC, KrF photoresists, and i-Line photoresists, which are widely used in advanced processes for logic and memory chips [2]. - By 2024, Hengkun is expected to capture approximately 10% of the domestic market for SOC products, with projected revenue from self-produced photoresist materials reaching 299.99 million yuan [2]. Group 2: Industry Context - The integrated circuit key materials sector is currently experiencing a golden development period, with the market size reaching 113.93 billion yuan in 2023 and expected to exceed 258.96 billion yuan by 2028, reflecting a compound annual growth rate of 14.4% [4]. - High-end products like KrF/ArF photoresists have a domestic production rate of less than 2%, indicating significant potential for domestic suppliers like Hengkun to replace imports [4]. Group 3: Competitive Landscape - The global photoresist market has been dominated by international giants such as JSR, Shin-Etsu Chemical, and DuPont, while precursor materials are largely monopolized by companies like Merck and Air Liquide [6]. - Hengkun has obtained 36 invention patents, with its products reaching international advanced levels, making it one of the first domestic companies to achieve mass production in advanced integrated circuit manufacturing [6]. Group 4: Financial Performance - From 2022 to 2024, Hengkun's revenue from self-produced products grew from 124 million yuan to 344 million yuan, achieving a compound annual growth rate of 66.89% [7]. - The company has supplied over 36,000 gallons of SOC and BARC products, successfully replacing similar products from foreign suppliers [7]. Group 5: Future Outlook - Hengkun's IPO is not only a growth story for the company but also a representation of China's semiconductor industry's breakthrough efforts [8]. - The company aims to enhance its R&D capabilities and production scale for high-end photoresist and precursor materials, solidifying its leading position in the domestic integrated circuit key materials sector [8].

Company Overview - Xiamen Hengkang New Materials Technology Co., Ltd. has received approval for its IPO on the Sci-Tech Innovation Board, marking a significant milestone for the company after over a decade in the integrated circuit key materials sector [2] - The company is one of the few domestic suppliers capable of mass-producing photolithography materials and precursors for 12-inch wafer manufacturing, reflecting a critical breakthrough in China's semiconductor industry [2] Core Business and Technology - Hengkang New Materials focuses on the research, production, and sales of photolithography materials and precursors, with a product range that includes SOC, BARC, KrF photoresists, and i-Line photoresists [3] - The company achieved a domestic market share of approximately 10% for SOC products in 2024, with revenues from self-produced photolithography materials reaching 299.99 million yuan [3] - Hengkang has developed a comprehensive R&D verification system with over 100 products, successfully completing national major science and technology projects [3] Industry Growth and Market Potential - The integrated circuit key materials sector is experiencing a golden development period, with the market size reaching 113.93 billion yuan in 2023 and projected to exceed 258.96 billion yuan by 2028, reflecting a compound annual growth rate of 14.4% [5] - High-end products like KrF/ArF photoresists have a domestic market penetration of less than 2%, indicating significant potential for domestic alternatives [6] Competitive Landscape - The global photolithography materials market is dominated by international giants such as JSR, Shin-Etsu Chemical, and DuPont, while the precursor materials market is monopolized by companies like Merck and Air Liquide [7] - Hengkang has obtained 36 invention patents, with its products reaching international advanced levels, and has become one of the first domestic companies to achieve mass production in advanced process applications [7] Financial Performance - From 2022 to 2024, the company's revenue from self-produced products grew from 124 million yuan to 344 million yuan, representing a compound annual growth rate of 66.89% [8] - The company has supplied over 36,000 gallons of SOC and BARC products, successfully replacing foreign competitors and breaking their monopoly [8] Strategic Positioning - Hengkang is accelerating the localization of upstream raw materials, supported by national policies and capital market dynamics [9] - The company's IPO journey exemplifies the growth of a "hard technology" enterprise and reflects the broader narrative of China's semiconductor industry overcoming challenges [11]

Group 1 - The global smart glasses market is expected to see a year-on-year shipment increase of 110% in the first half of 2025, with a compound annual growth rate of over 60% from 2024 to 2029, where AI smart glasses will account for 78% of the market [1] - Meta holds a 73% market share with its Ray-Ban series, while new brands like Xiaomi and RayNeo are accelerating market expansion [1] - Domestic semiconductor equipment has achieved dual breakthroughs, including the mass production of 28nm electron beam measurement equipment by Wuxi Gexin Yuedong Technology, filling a domestic technology gap, and the first commercial electron beam lithography machine "Xizhi" entering the testing phase with a minimum line width of 8nm, providing key technical support for quantum chip research and development [1] Group 2 - The electronic industry is in a mild recovery phase, with steady demand growth in AI servers, AIOT, and equipment materials, while the self-controllable capability of the semiconductor industry chain continues to improve [1] - The Guotai Science and Technology Chip ETF (589100) tracks the Science and Technology Chip Index (000685), which can have a daily fluctuation of up to 20%, reflecting the overall performance of listed companies in the semiconductor sector [1] - The Science and Technology Chip Index consists of 50 constituent stocks, focusing on high-growth potential and technological breakthroughs in semiconductor enterprises, showcasing the trend of self-controllable development in China's semiconductor industry [1]

Group 1: Healthcare and Biopharmaceutical Industry - The healthcare and biopharmaceutical sector saw an overall increase of 3.08% from August 11 to August 15, outperforming the CSI 300 index by 0.71 percentage points. Year-to-date, the sector has risen by 25.02%, ranking fourth among 31 industries [5][6]. - The National Healthcare Security Administration announced the preliminary review list for the 2025 National Basic Medical Insurance and commercial insurance drug directories, with 534 drugs passing the basic insurance review and 121 passing the commercial insurance review. Notably, 79 drugs passed both reviews, including various innovative therapies [6][7]. - Investment recommendations focus on innovative drugs, CXO, medical devices, traditional Chinese medicine, chain pharmacies, and medical services, as the sector is expected to benefit from ongoing policy support for innovative drugs [7][9]. Group 2: Electronics Industry - The global smart glasses market experienced a remarkable growth of 110% year-on-year in the first half of 2025, with expectations of maintaining a compound annual growth rate of over 60% from 2024 to 2029. Meta leads the market with a 73% share [10][11]. - Domestic semiconductor equipment has achieved significant breakthroughs, including the mass production of 28nm electron beam measurement equipment and the testing of the first commercial electron beam lithography machine, enhancing China's semiconductor industry autonomy [12][13]. - The electronics sector outperformed the market with a 7.02% increase, driven by strong demand recovery and price stabilization. Key areas of focus include AI server supply chains, AIOT, equipment materials, and automotive electronics [14][15].

Investment Rating - The report maintains an "Accumulate" rating for the basic chemical industry [5] Core Viewpoints - The supply of nitrogen trifluoride (NF₃) is expected to tighten due to incidents affecting major overseas suppliers, which may lead to an increase in market prices and a potential rise in market share for domestic manufacturers [2][4][25] - The global market for nitrogen trifluoride is projected to reach $1.783 billion in 2025, with a compound annual growth rate (CAGR) of 11.6% from 2025 to 2033 [25][27] Summary by Sections 1. Industry Overview - A fire at Kanto Denka Kogyo Co., a major supplier of NF₃, has resulted in a production halt for one of its lines, while Mitsui Chemicals has announced its exit from the NF₃ business [1][21][22] - Current domestic production capacity for NF₃ in China is approximately 31,800 tons/year, with planned expansions reaching 46,600 tons/year [2][25][26] 2. Market Dynamics - As of August 15, 2025, the average market price for NF₃ in China is around 80,000 yuan/ton, with expectations for price increases due to supply shortages [2][27] - The demand for NF₃ is anticipated to rise significantly, driven by growth in the semiconductor and display panel industries [25][27] 3. Key Companies to Watch - Companies with NF₃ or other electronic specialty gas products include China Shipbuilding Special Gas, Nanda Optoelectronics, and Huahua Technology [4][35] - In the context of increasing importance of domestic semiconductor supply chains, attention is also drawn to companies producing semiconductor materials beyond electronic specialty gases [4][35] 4. Price Trends - Recent price increases have been noted in various chemical products, with NF₃ expected to follow suit due to supply constraints [18][19][27] - The report highlights the performance of the basic chemical sector, with a notable increase in stock prices for key companies in the past week [9][15]

Core Viewpoint - Xi'an Yiswei Material Technology Co., Ltd. (referred to as "Xi'an Yicai") has successfully passed its IPO application on the Sci-Tech Innovation Board, marking it as the first unprofitable company accepted by the Shanghai Stock Exchange after the release of the "New National Nine Articles" and "Science and Technology Eight Articles" [2] Group 1: Company Overview - Established in 2016, Xi'an Yicai focuses on the research, production, and sales of 12-inch silicon wafers, which are critical materials in the semiconductor industry, accounting for over 75% of global silicon wafer shipments [2] - As of the end of 2024, the company has achieved a monthly shipment volume of 521,200 wafers, ranking first among manufacturers in mainland China and sixth globally [2][3] Group 2: Technology and Production Capacity - Xi'an Yicai has developed a core technology system encompassing five major processes: crystal pulling, shaping, polishing, cleaning, and epitaxy, with key indicators on par with the top five global manufacturers [3] - The company has a strategic plan from 2020 to 2035 to establish 2 to 3 core manufacturing bases and several modern intelligent manufacturing plants, with the first base already operational in Xi'an [3] - By the end of 2024, the combined production capacity is expected to reach 710,000 wafers per month, with a target of 1.2 million wafers per month by 2026, potentially meeting about 40% of mainland China's demand for 12-inch silicon wafers [3] Group 3: Financial Performance - Xi'an Yicai's revenue for 2022, 2023, and 2024 was 1.055 billion, 1.474 billion, and 2.121 billion respectively, with a compound annual growth rate of 41.83% [5][6] - Despite the revenue growth, the company reported net losses of 412 million, 578 million, and 738 million for the same years, totaling a cumulative loss of 1.728 billion [6] - The losses are attributed to high fixed costs from heavy asset investments, with total investments in the two factories exceeding 23.5 billion [6] Group 4: Market Position and Future Outlook - The global 12-inch silicon wafer market is dominated by a few foreign companies, with Xi'an Yicai holding a market share of approximately 6-7% [7] - The successful IPO approval signifies a growing acceptance of "hard technology" companies in the Chinese capital market, providing funding opportunities for tech firms that are not yet profitable [7] - Xi'an Yicai's future trajectory will be crucial for observing the development of China's semiconductor materials industry, as it faces challenges such as overcapacity and price declines [7]